المؤلفون: Alison Callahan, Alejandro Schuler, Nigam H. Shah, Juan M. Banda, Anthony Reckard, Rohit Vashisht, Christian G. Reich, George Hripcsak, Martijn J. Schuemie, James Weaver, Mark M. Shervey, Mui Van Zandt, Sanghyung Jin, Joel T. Dudley, Yonghui Wu, Kenneth Jung, Peng Jin, Rae Woong Park, Karthik Natrajan, Kipp W. Johnson, Hua Xu, Patrick B. Ryan, Li Li

المصدر: JAMA Network Open

مصطلحات موضوعية: Male, medicine.medical_specialty, endocrine system diseases, Type 2 diabetes, 01 natural sciences, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Internal medicine, Humans, Hypoglycemic Agents, Medicine, 030212 general & internal medicine, 0101 mathematics, Medical prescription, Original Investigation, Glycated Hemoglobin, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Research, 010102 general mathematics, Hazard ratio, nutritional and metabolic diseases, General Medicine, medicine.disease, Metformin, 3. Good health, Online Only, Diabetes and Endocrinology, Sulfonylurea Compounds, Hemoglobin A, Diabetes Mellitus, Type 2, Eye disorder, Female, Thiazolidinediones, Kidney disorder, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34c8657a2b522d5da75897fefe16d8b2
https://doi.org/10.1001/jamanetworkopen.2018.1755